COMPANY NEWSCompany News Icon

AnthroTronix and Nview Health Collaboration Powers Seamless Assessment of Cognition and Behavioral Health

AnthroTronix and Nview Health Collaboration Powers Seamless Assessment of Cognition and Behavioral Health — Provides Consistent Measurement of Cognitive and Behavioral Health in One Place — SILVER SPRING, Md. – AnthroTronix and Nview Health announced today they have partnered to combine two technologies to test both a person’s cognitive function and their behavioral health. Used together, these technologies can provide healthcare practitioners with better insight into a person’s complete behavioral health and wellness. AnthroTronix’s DANA TM is an FDA cleared clinical neurocognitive assessment tool that uses a smartphone or tablet to measure and monitor changes in a person’s brain/cognitive function. The app can help clinicians track cognitive function for conditions such as depression, dementia/Alzheimer’s Disease, and Post-Traumatic Stress Disorder. “Cognitive function and behavioral health are closely linked,” said AnthroTronix CEO Cori Lathan. “Our behavioral health status effects our cognitive efficiency so to get a clear picture of a person’s brain health, it’s important to test both. Our partnership with Nview Health now enables healthcare providers the ability to do that.” Nview’s diagnostic instrument, the M.I.N.I. — Mini International Neuropsychiatric Interview — is a short, structured diagnostic interview designed to evaluate the most common DSM-5 and ICD-10 psychiatric disorders. It enables healthcare professionals to rapidly deliver a behavioral health diagnosis and has been used in patient care and clinical research for more than 25 years. “Our partnership with AnthroTronix now allows us to measure an individual’s cognitive status, which is essential to the care and treatment of behavioral health disorders,” said Nview Health Chief Executive Officer and Co-Founder Thomas R. Young, M.D. ### About AnthroTronix AnthroTronix, an engineering research and development company, produces human-centered technologies that advance health, communication, education, and defense. We... read more

Health-eBrain Study to Launch Phase II

Health-eBrain Study to Launch Phase II Mobile Platform Captures and Analyzes Cognitive and Emotional Health of Caregivers of Alzheimer’s Patients Toronto – BrightFocus Foundation, Geoffrey Beene Foundation Alzheimer’s Initiative, AnthroTronix, and Mindoula, have launched Phase II of the Health-eBrain Study, investigating the impact the Alzheimer’s caregiving experience has on brain and behavioral health. The announcement will be made at the Global Alliance for Women’s Brain Health Luncheon at the Alzheimer’s Association International Conference in Toronto on July 26, 2016. More than 1,000 caregivers were recruited for Phase I of the study, which documented cognitive impairment in the informal caregiver population compared with matched controls. An informal caregiver is defined as an unpaid person without formal training, such as a family member, who provides care for an individual with dementia. “Given the results we found in Phase I, we have set two goals for Phase II. The first is to look at caregiver stressors that could be possible causes for this cognitive impairment as well as provide an intervention that could help these caregivers with their mental health,” said Dr. Cori Lathan, board chair and CEO of AnthroTronix. “The rigor of science can help us better understand and improve caregivers’ health,” said BrightFocus President and CEO Stacy Pagos Haller. “BrightFocus is honored to support such innovative research.” In Phase II, an international cohort of caregivers will use DANATM, AnthroTronix’s FDA-cleared brain health assessment mobile app, to assess their cognitive function over 12 weeks. DANA provides detailed feedback about brain function that can be analyzed for changes over time. All participants in Phase II will use DANA, with some participants also using Mindoula. DANA will track... read more

AnthroTronix CEO to Conduct Davos Brain Challenge and Discuss Technology and the Brain at the Annual Meeting of the New Champions

WHO:   AnthroTronix (@AnthroTronix), a leader in digital health technology and engineering research and development committed to optimizing the interaction between people and technology. WHAT: At the World Economic Forum’s Annual Meeting of the New Champions, AnthroTronix CEO Dr. Cori Lathan (@clathan) will conduct the Davos Brain Challenge using its FDA-cleared DANA brain health assessment app. AnthroTronix held a similar exhibit at the World Economic Forum Annual Meeting in Davos-Klosters, Switzerland, earlier this year. AnthroTronix will invite attendees to assess their brain health and discover how innovative digital capabilities are transforming the way we assess and monitor our brain health. In addition, Dr. Lathan will discuss how digital technology, such as DANA, is improving our understanding of the brain and how we identify conditions and changes in cognitive function. Dr. Lathan has been named a Technology Pioneer and Young Global Leader by the World Economic Forum and is currently chair of their Global Agenda Council on Artificial Intelligence (AI) and Robotics. WHERE: Davos Brain Challenge Brain Hub, Works in Progress Exhibition Meijiang Convention & Exhibition Centre Tianjin, People’s Republic of China WHEN: June 26 – 28, 2016 Download PDF of press... read more

IN THE NEWSCompany News Icon